Dexterra Group Inc.

TSX:DXT.TO

Specialty Business Services

Industrials
$18.83 +0.15%

+$0.02 today

Market cap
$1.18B
Beta
0.65
P/E (TTM)
17.8
EPS (TTM)
$0.73
Dividend yield
2.99%
52W Low $8.80High $13.93

Volume 0.06M

Average 0.03M

DXT.TO Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Dexterra Group Inc.TSX: DXT.TO

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development remains negative

Q1 FY2026 research & development was CA$0, compared with CA$0 a year earlier. Trailing-twelve-month research & development was CA$0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$0— QoQ
Last fiscal yearDec 2025
CA$0— YoY
LTMMar 2026
CA$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

CAD · from the income statement

Latest · FY2025
0 CAD
Year-over-year change
—

Research & Development vs competitors

How DXT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Research & development amounts to 0.0% of revenue for DXT.TO, versus a peer median of 0.0%.
DXT.TO Competitors
Research & Development for DXT.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CGY.TOCalian Group Ltd.LTM Mar 2026CA$12.33M CAD+0.9%+30.0%1.5%
DXT.TODexterra Group Inc.LTM Mar 2026CA$0 CAD——0.0%
ALC.TOAlgoma Central CorporationLTM Mar 2026CA$0 CAD——0.0%
ADEN.TOADENTRA Inc.LTM Mar 2026$0 USD——0.0%
CHR.TOChorus Aviation Inc.LTM Mar 2026CA$0 CAD——0.0%
WJX.TOWajax CorporationLTM Mar 2026CA$0 CAD——0.0%
DIV.TODiversified Royalty Corp.LTM Mar 2026CA$0 CAD——0.0%
KBL.TOK-Bro Linen Inc.LTM Mar 2026CA$0 CAD——0.0%
AFN.TOAg Growth International Inc.LTM Mar 2026CA$0 CAD——0.0%
Peer median (excluding DXT.TO) —+0.9%+30.0%0.0%

Competitors are the stored peer set for DXT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue733.38M971.52M1.12B1B1.04B
Cost of Revenue622.84M880.97M786.75M843M896.98M
Gross Profit110.54M90.55M141.02M160.03M144.27M
Gross Margin15.1%9.3%12.6%16.0%13.9%
Research & Development00000
Selling, General & Admin37.15M42.22M43.92M58.08M79.6M
Operating Expenses74.59M80.82M82.04M92.93M79.6M
Depreciation & Amortization38.06M38.61M34.98M35.21M42.34M
EBITDA74.02M63.44M93.96M101.9M107.02M
EBITDA Margin10.1%6.5%8.4%10.2%10.3%
Operating Income35.96M10.15M58.99M67.1M64.67M
Operating Margin4.9%1.0%5.3%6.7%6.2%
Interest Income00000
Interest Expense5.1M8.95M13.44M13.06M11.34M
Other Income / Expenses(2.62M)(6.93M)(11.48M)(13.46M)(9.98M)
Income Before Tax33.34M3.22M47.5M53.64M54.69M
Pre-Tax Margin4.5%0.3%4.3%5.3%5.3%
Income Tax Expense8.71M(495K)11.69M16.1M13.89M
Net Income24.36M3.43M26.62M19.87M40.51M
Net Margin3.3%0.4%2.4%2.0%3.9%
EPS (Basic)0.370.050.410.310.65
EPS (Diluted)0.370.050.410.310.64
Weighted Avg Shares65.82M65.21M64.99M64.02M62.42M
Weighted Avg Shares (Diluted)65.42M65.49M65.22M64.3M63.36M

Dexterra Group Inc.

TSX:DXT.TO

Intrinsic Alpha fair value

Locked

Current Price

$18.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.